When was LevitasBio founded?

LevitasBio was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is LevitasBio located?

LevitasBio is headquartered in San Francisco, United States.

How many employees does LevitasBio have?

As of Apr 30, 2026, the latest employee count at LevitasBio is 29.

Is LevitasBio a funded company?

LevitasBio is a funded company, having raised a total of $73.8M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 03, 2017.

When was the latest funding round of LevitasBio?

LevitasBio's latest funding was a $***** Series C round on Mar 28, 2024, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $424M in funding in 2026 to date.

Where does LevitasBio rank among its competitors?

LevitasBio ranks 10th amongst 80 active competitors, of which 27 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Mission Bio, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of LevitasBio?

LevitasBio's top competitors include 10X Genomics, Mission Bio and LUMICKS. Among them, Mission Bio secured the most recent funding round in August, 2025.

LevitasBio - 2026 Company Profile, Team, Funding & Competitors

LevitasBio is a series C company based in San Francisco (United States), founded in 2017 by Gozde Durmus, Utkan Demirci and Lars Steinmetz. It operates as a Developer of single-cell imaging and profiling platform based on magnetic levitation technology. LevitasBio has raised $73.8M in funding from Decheng Capital and Novalis LifeSciences. The company has 80 active competitors, including 27 funded and 9 that have exited. Its top competitors include companies like 10X Genomics, Mission Bio and LUMICKS.

Company Details

Developer of single-cell imaging and profiling platform based on magnetic levitation technology. The company is developing a single-cell imaging and profiling platform based on magnetic levitation technology called the levitation image cytometry platform. The company claims that it would be a label-free & universal method of cell analysis. This platform will be used in therapeutics, diagnostic & research applications.

Website: levitasbio.com
Social

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Series C

Total Funding

$73.8M in 4 rounds

Latest Funding Round

Series C, Mar 28, 2024, $*****

Investors

Decheng Capital & 2 more

Ranked

10^th among 80 active competitors

Employee Count

29 as on Apr 30, 2026

Similar Companies

10X Genomics & 91 more

View LevitasBio's full profile

LevitasBio has raised a total funding of $73.8M over 4 rounds. Its first funding round was on Aug 03, 2017. LevitasBio has 3 institutional investors.

Here is the list of recent funding rounds of LevitasBio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 28, 2024	5591755	Series C	7425521	9293304	8917805	2245337
Oct 24, 2022	8414232	Series C	8861044	6327351	7711065	Pavilion Capital Partners & 1 more
Jan 06, 2021	4231003	Series B	9616792	3434848	6626805	9199431

Access funding benchmarks and valuations. Sign up today!

View details of LevitasBio's funding rounds and investors

The founders of LevitasBio are Gozde Durmus, Utkan Demirci and Lars Steinmetz.

Here are the details of LevitasBio's key team members:

Gozde Durmus: Co-Founder of LevitasBio.
Contact Info: 2 email addresses
Utkan Demirci: Co-Founder of LevitasBio.
Lars Steinmetz: Co-Founder of LevitasBio.

View details of LevitasBio's Founder profiles and Board Members

LevitasBio's employee count trend

LevitasBio has 29 employees as of Apr 26. Here is LevitasBio's employee count trend over the years:

Uncover LevitasBio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LevitasBio include 10X Genomics, Mission Bio and LUMICKS. Here is the list of Top 10 competitors of LevitasBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	10X Genomics 2012, Pleasanton (United States), Public	Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis	$243M	Fidelity Investments, Meritech & 13 others	77/100
2nd	Mission Bio 2014, San Francisco (United States), Series C	Provider of single cell multiomics platform for genotypic and phenotypic analysis	$120M	Cota Capital, Ally Bridge Group & 27 others	65/100
3rd	LUMICKS 2014, Amsterdam (Netherlands), Series D	Manufacturer of optical tweezers for single molecule analysis instruments	$93.4M	Farallon Capital Management, Lauxera Capital Partners ... & 11 others	63/100
4th	Atrandi Biosciences 2016, Vilnius (Lithuania), Series A	A life sciences tool company transforming single-cell research with its patented Semi-Permeable Capsule(SPC) technology, enabling high-throughput and multi-step workflows	$31M	Lux Capital, Practica Capital & 4 others	63/100
5th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	61/100
6th	Xcell Biosciences 2012, San Francisco (United States), Series B	Developer of cell culture analysis device for cancer research	$40.9M	Casdin Capital, HBM Genomics & 10 others	60/100
7th	Biolog 1984, Hayward (United States), Series A	Provider of cell-based phenotyping technologies and assays	$33.6M	Broadoak Capital Partners, RCT & 2 others	58/100
8th	IsoPlexis 2012, New Haven (United States), Acquired	Developer of multiplexed single-cell analysis tools for the diagnostics and life science research	$186M	Northpond Ventures, YEI Innovation Fund & 14 others	53/100
9th	Axion Biosystems 2007, Atlanta (United States), Acquired	Develops multi-electrode array technology to provide access to cellular information analysis	$20.3M	GRA Venture Fund, Georgia Research Alliance ... & 3 others	53/100
10th	LevitasBio 2017, San Francisco (United States), Series C	Developer of single-cell imaging and profiling platform based on magnetic levitation technology	$73.8M	Novalis LifeSciences, Decheng Capital & 1 others	49/100